Company Data

XORTX Therapeutics Inc.

Market Cap
Price Target
Refer to Report
52wk Range
$0.08 - $0.105
Advanced Market Data


XORTX Therapeutics Inc is focused on developing drug therapies for the orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.